IN8BIO
INAB Insider Trades:
all
Powered by unusualwhales.com
Ticker
Trade Date
Filing Date
Name
Title
Code
Security
Amount
Price
Value
Trans.
10b5-1
Director
10% Owner
Mcap/AUM
2025-05-01
2025-05-07
HO WILLIAM TAI-WEI
PRESIDENT AND CEO
D - Sale to Issuer
Series A Warrants (right to buy)
-81,967
1
$173.08M
2025-05-01
2025-05-07
HO WILLIAM TAI-WEI
PRESIDENT AND CEO
A - Grant
Pre-Funded Warrant (right to buy)
81,967
$0.00
1
$173.08M
2025-04-30
2025-05-07
ROCHLIN KATE
Chief Operating Officer
M - Exercise
Series A Warrants (right to buy)
-12,295
$0.00
1
$173.08M
2025-04-30
2025-05-07
MCCALL PATRICK
CHIEF FINANCIAL OFFICER
M - Exercise
Common Stock
15,000
$0.00
1
$173.08M
2025-04-30
2025-05-07
MCCALL PATRICK
CHIEF FINANCIAL OFFICER
M - Exercise
Series A Warrants (right to buy)
-15,000
$0.00
1
$173.08M
2025-04-30
2025-05-07
BRANDT PETER
M - Exercise
Series B Warrants (right to buy)
-81,967
$0.00
1
$173.08M
2025-04-30
2025-05-07
BRANDT PETER
M - Exercise
Series A Warrants (right to buy)
-81,967
$0.00
1
$173.08M
2025-04-30
2025-05-07
ROEMER ALAN
M - Exercise
Series B Warrants (right to buy)
-11,000
$0.00
1
$173.08M
2025-04-30
2025-05-07
ROCHLIN KATE
Chief Operating Officer
M - Exercise
Common Stock
12,295
$0.00
1
$173.08M
2025-04-27
2025-05-07
ROCHLIN KATE
Chief Operating Officer
D - Sale to Issuer
Series B Warrants (right to buy)
-12,295
1
$173.08M
2025-04-27
2025-05-07
EPPERLY CORINNE
D - Sale to Issuer
Series B Warrants (right to buy)
-81,967
1
$173.08M
2025-04-27
2025-05-07
BRANDT PETER
D - Sale to Issuer
Series A Warrants (right to buy)
-81,967
1
$173.08M
2025-04-27
2025-05-07
ROCHLIN KATE
Chief Operating Officer
D - Sale to Issuer
Series A Warrants (right to buy)
-12,295
1
$173.08M
2025-04-27
2025-05-07
HO WILLIAM TAI-WEI
PRESIDENT AND CEO
A - Grant
Series B Warrants (right to buy)
81,967
1
$173.08M
2025-04-27
2025-05-07
LAMB LAWRENCE
EVP and CSO
A - Grant
Series B Warrants (right to buy)
1,639
1
$173.08M
2025-04-27
2025-05-07
MCCALL PATRICK
CHIEF FINANCIAL OFFICER
A - Grant
Series A Warrants (right to buy)
15,000
1
$173.08M
2025-04-27
2025-05-07
MCCALL PATRICK
CHIEF FINANCIAL OFFICER
A - Grant
Series B Warrants (right to buy)
20,492
1
$173.08M
2025-04-27
2025-05-07
ROCHLIN KATE
Chief Operating Officer
A - Grant
Series A Warrants (right to buy)
12,295
1
$173.08M
2025-04-27
2025-05-07
ROCHLIN KATE
Chief Operating Officer
A - Grant
Series B Warrants (right to buy)
12,295
1
$173.08M
2025-04-27
2025-05-07
BRANDT PETER
D - Sale to Issuer
Series B Warrants (right to buy)
-81,967
1
$173.08M
2025-04-27
2025-05-07
GRAFF JEREMY
D - Sale to Issuer
Series B Warrants (right to buy)
-2,049
1
$173.08M
2025-04-27
2025-05-07
HO WILLIAM TAI-WEI
PRESIDENT AND CEO
D - Sale to Issuer
Series B Warrants (right to buy)
-81,967
1
$173.08M
2025-04-27
2025-05-07
LAMB LAWRENCE
EVP and CSO
D - Sale to Issuer
Series B Warrants (right to buy)
-1,639
1
$173.08M
2025-04-27
2025-05-07
MCCALL PATRICK
CHIEF FINANCIAL OFFICER
D - Sale to Issuer
Series A Warrants (right to buy)
-15,000
1
$173.08M
2025-04-27
2025-05-07
MCCALL PATRICK
CHIEF FINANCIAL OFFICER
D - Sale to Issuer
Series B Warrants (right to buy)
-20,492
1
$173.08M
2025-02-05
2025-02-07
HO WILLIAM TAI-WEI
PRESIDENT AND CEO
A - Grant
Employee Stock Option (right to buy)
912K
$0.00
1
$173.08M
2025-02-05
2025-02-07
LAMB LAWRENCE
EVP and CSO
A - Grant
Employee Stock Option (right to buy)
307K
$0.00
1
$173.08M
2025-02-05
2025-02-07
MCCALL PATRICK
CHIEF FINANCIAL OFFICER
A - Grant
Employee Stock Option (right to buy)
343K
$0.00
1
$173.08M
2025-02-05
2025-02-07
ROCHLIN KATE
Chief Operating Officer
A - Grant
Employee Stock Option (right to buy)
339K
$0.00
1
$173.08M
2024-12-19
2024-12-23
HO WILLIAM TAI-WEI
PRESIDENT AND CEO
A - Grant
Employee Stock Option (right to buy)
1.19M
$0.00
1
$173.08M
2024-12-19
2024-12-23
LAMB LAWRENCE
EVP and CSO
A - Grant
Employee Stock Option (right to buy)
287K
$0.00
1
$173.08M
2024-12-19
2024-12-23
MCCALL PATRICK
CHIEF FINANCIAL OFFICER
A - Grant
Employee Stock Option (right to buy)
290K
$0.00
1
$173.08M
2024-12-19
2024-12-23
ROCHLIN KATE
Chief Operating Officer
A - Grant
Employee Stock Option (right to buy)
303K
$0.00
1
$173.08M
2024-10-04
2024-10-08
HO WILLIAM TAI-WEI
PRESIDENT AND CEO
A - Grant
Series A Warrants (right to buy)
81,967
1
$173.08M
2024-10-04
2024-10-08
HO WILLIAM TAI-WEI
PRESIDENT AND CEO
A - Grant
Series C Warrants (right to buy)
127K
1
$173.08M
2024-10-04
2024-10-08
MCCALL PATRICK
CHIEF FINANCIAL OFFICER
A - Grant
Series A Warrants (right to buy)
20,492
1
$173.08M
2024-10-04
2024-10-08
MCCALL PATRICK
CHIEF FINANCIAL OFFICER
A - Grant
Series C Warrants (right to buy)
25,316
1
$173.08M
2024-10-04
2024-10-08
ROCHLIN KATE
Chief Operating Officer
A - Grant
Series A Warrants (right to buy)
12,295
1
$173.08M
2024-10-04
2024-10-08
ROCHLIN KATE
Chief Operating Officer
A - Grant
Series C Warrants (right to buy)
25,316
1
$173.08M
2024-10-04
2024-10-08
BRANDT PETER
D - Sale to Issuer
Series A Warrants (right to buy)
-81,967
1
$173.08M
2024-10-04
2024-10-08
HO WILLIAM TAI-WEI
PRESIDENT AND CEO
D - Sale to Issuer
Series A Warrants (right to buy)
-81,967
1
$173.08M
2024-10-04
2024-10-08
MCCALL PATRICK
CHIEF FINANCIAL OFFICER
D - Sale to Issuer
Series A Warrants (right to buy)
-20,492
1
$173.08M
2024-10-04
2024-10-08
ROCHLIN KATE
Chief Operating Officer
D - Sale to Issuer
Series A Warrants (right to buy)
-12,295
1
$173.08M
2024-09-04
2024-09-05
GOSWAMI TRISHNA
Chief Medical Officer
A - Grant
Employee Stock Option (right to buy)
250K
$0.00
1
$173.08M
2024-09-04
2024-09-05
HO WILLIAM TAI-WEI
PRESIDENT AND CEO
A - Grant
Employee Stock Option (right to buy)
500K
$0.00
1
$173.08M
2024-09-04
2024-09-05
LAMB LAWRENCE
EVP and CSO
A - Grant
Employee Stock Option (right to buy)
250K
$0.00
1
$173.08M
2024-09-04
2024-09-05
MCCALL PATRICK
CHIEF FINANCIAL OFFICER
A - Grant
Employee Stock Option (right to buy)
250K
$0.00
1
$173.08M
2024-09-04
2024-09-05
ROCHLIN KATE
Chief Operating Officer
A - Grant
Employee Stock Option (right to buy)
250K
$0.00
1
$173.08M
2024-02-07
2024-02-08
GOSWAMI TRISHNA
CHIEF MEDICAL OFFICER
A - Grant
Employee Stock Option (right to buy)
176K
$0.00
1
$173.08M
2024-02-07
2024-02-08
HO WILLIAM TAI-WEI
PRESIDENT AND CEO
A - Grant
Employee Stock Option (right to buy)
502K
$0.00
1
$173.08M
2024-02-07
2024-02-08
LAMB LAWRENCE
EVP AND CSO
A - Grant
Employee Stock Option (right to buy)
169K
$0.00
1
$173.08M
2024-02-07
2024-02-08
MCCALL PATRICK
CHIEF FINANCIAL OFFICER
A - Grant
Employee Stock Option (right to buy)
189K
$0.00
1
$173.08M
2024-02-07
2024-02-08
ROCHLIN KATE
CHIEF OPERATING OFFICER
A - Grant
Employee Stock Option (right to buy)
186K
$0.00
1
$173.08M
2023-12-13
2023-12-15
GOSWAMI TRISHNA
Chief Medical Officer
A - Grant
Series A Warrants (right to buy)
4,098
1
$173.08M
2023-12-13
2023-12-15
GOSWAMI TRISHNA
Chief Medical Officer
A - Grant
Series B Warrants (right to buy)
4,098
1
$173.08M
2023-12-13
2023-12-15
HO WILLIAM TAI-WEI
President and CEO
A - Grant
Series A Warrants (right to buy)
81,967
1
$173.08M
2023-12-13
2023-12-15
HO WILLIAM TAI-WEI
President and CEO
A - Grant
Series B Warrants (right to buy)
81,967
1
$173.08M
2023-12-13
2023-12-15
LAMB LAWRENCE
EVP and CSO
A - Grant
Series A Warrants (right to buy)
1,639
1
$173.08M
2023-12-13
2023-12-15
LAMB LAWRENCE
EVP and CSO
A - Grant
Series B Warrants (right to buy)
1,639
1
$173.08M
2023-12-13
2023-12-15
MCCALL PATRICK
Chief Financial Officer
A - Grant
Series A Warrants (right to buy)
20,492
1
$173.08M
2023-12-13
2023-12-15
MCCALL PATRICK
Chief Financial Officer
A - Grant
Series B Warrants (right to buy)
20,492
1
$173.08M
2023-12-13
2023-12-15
ROCHLIN KATE
Chief Operating Officer
A - Grant
Series A Warrants (right to buy)
12,295
1
$173.08M
2023-12-13
2023-12-15
ROCHLIN KATE
Chief Operating Officer
A - Grant
Series B Warrants (right to buy)
12,295
1
$173.08M
2023-08-25
2023-08-28
MCCALL PATRICK
Chief Financial Officer
P - Purchase
Common Stock
1,000
$1.00
1,000
1
$173.08M
2023-08-24
2023-08-28
HO WILLIAM TAI-WEI
President and CEO
P - Purchase
Common Stock
23,800
$1.00
23,800
1
$173.08M
2023-06-21
2023-06-23
LAMB LAWRENCE
EVP and CSO
A - Grant
Employee Stock Option (right to buy)
77,600
$0.00
1
$173.08M
2023-06-21
2023-06-23
GOSWAMI TRISHNA
Chief Medical Officer
A - Grant
Employee Stock Option (right to buy)
134K
$0.00
1
$173.08M
2023-06-21
2023-06-23
HO WILLIAM TAI-WEI
President and CEO
A - Grant
Employee Stock Option (right to buy)
394K
$0.00
1
$173.08M
2023-06-21
2023-06-23
MCCALL PATRICK
Chief Financial Officer
A - Grant
Employee Stock Option (right to buy)
87,150
$0.00
1
$173.08M
2023-06-21
2023-06-23
ROCHLIN KATE
Chief Operating Officer
A - Grant
Employee Stock Option (right to buy)
67,800
$0.00
1
$173.08M
2023-04-14
2023-06-23
HO WILLIAM TAI-WEI
President and CEO
A - Grant
Employee Stock Option (right to buy)
394K
$0.00
1
$173.08M
2023-04-14
2023-04-18
ROCHLIN KATE
Chief Operating Officer
A - Grant
Employee Stock Option (right to buy)
200K
$0.00
1
$173.08M
2023-04-14
2023-04-18
LAMB LAWRENCE
EVP and CSO
A - Grant
Employee Stock Option (right to buy)
200K
$0.00
1
$173.08M
2023-04-14
2023-04-18
MCCALL PATRICK
Chief Financial Officer
A - Grant
Employee Stock Option (right to buy)
200K
$0.00
1
$173.08M
2023-04-14
2023-04-18
GOSWAMI TRISHNA
Chief Medical Officer
A - Grant
Employee Stock Option (right to buy)
200K
$0.00
1
$173.08M
2023-04-14
2023-04-18
HO WILLIAM TAI-WEI
President and CEO
A - Grant
Employee Stock Option (right to buy)
394K
$0.00
1
$173.08M
2022-10-21
2022-10-25
MCCALL PATRICK
Chief Financial Officer
A - Grant
Employee Stock Option (right to buy)
59,796
$0.00
1
$173.08M
2022-10-21
2022-10-25
ROCHLIN KATE
Chief Operating Officer
A - Grant
Employee Stock Option (right to buy)
60,555
$0.00
1
$173.08M
2022-10-21
2022-10-25
GOSWAMI TRISHNA
Chief Medical Officer
A - Grant
Employee Stock Option (right to buy)
68,427
$0.00
1
$173.08M
2022-10-21
2022-10-25
HO WILLIAM TAI-WEI
President, CEO and CFO
A - Grant
Employee Stock Option (right to buy)
83,265
$0.00
1
$173.08M
2022-10-21
2022-10-25
LAMB LAWRENCE
EVP and CSO
A - Grant
Employee Stock Option (right to buy)
62,826
$0.00
1
$173.08M
2022-08-16
2022-08-18
GOSWAMI TRISHNA
Chief Medical Officer
P - Purchase
Common Stock
2,631
$2.00
5,262
1
$173.08M
2022-08-16
2022-08-18
HO WILLIAM TAI-WEI
President, CEO and CFO
P - Purchase
Common Stock
26,315
$2.00
52,630
1
$173.08M
2022-08-16
2022-08-18
MCCALL PATRICK
Chief Financial Officer
P - Purchase
Common Stock
5,263
$2.00
10,526
1
$173.08M
2022-08-16
2022-08-18
ROCHLIN KATE
Chief Operating Officer
P - Purchase
Common Stock
5,263
$2.00
10,526
1
$173.08M
2022-05-05
2022-05-09
LAMB LAWRENCE
EVP and CSO
M - Exercise
Employee Stock Option (right to buy)
-26,204
$0.00
1
$173.08M
2022-02-15
2022-02-17
GOSWAMI TRISHNA
Chief Medical Officer
A - Grant
Employee Stock Option (right to buy)
90,500
$0.00
1
$173.08M
2022-02-15
2022-02-17
HO WILLIAM TAI-WEI
President, CEO and CFO
A - Grant
Employee Stock Option (right to buy)
255K
$0.00
1
$173.08M
2022-02-15
2022-02-17
LAMB LAWRENCE
EVP and CSO
A - Grant
Employee Stock Option (right to buy)
62,500
$0.00
1
$173.08M
2022-02-15
2022-02-17
MCCALL PATRICK
Chief Financial Officer
A - Grant
Employee Stock Option (right to buy)
84,500
$0.00
1
$173.08M
2022-02-15
2022-02-17
ROCHLIN KATE
Chief Operating Officer
A - Grant
Employee Stock Option (right to buy)
96,000
$0.00
1
$173.08M
2021-11-19
2021-11-23
GOSWAMI TRISHNA
Chief Medical Officer
A - Grant
Employee Stock Option (right to buy)
250K
$0.00
1
$173.08M
2021-08-03
2021-08-03
LAMB LAWRENCE
EVP and CSO
A - Grant
Employee Stock Option (right to buy)
22,082
$0.00
1
$173.08M
2021-08-03
2021-08-03
FLETCHER AARON G.L.
C - Conversion
Series A Preferred Stock
-6.02M
$0.00
7
$173.08M
2021-08-03
2021-08-03
HO WILLIAM TAI-WEI
President, CEO and CFO
C - Conversion
Series A Preferred Stock
-2,792
$0.00
1
$173.08M
2021-08-03
2021-08-03
HO WILLIAM TAI-WEI
President, CEO and CFO
C - Conversion
Common Stock
3,070
1
$173.08M
2021-07-29
2021-08-02
HO WILLIAM TAI-WEI
President, CEO and CFO
A - Grant
Employee Stock Option (right to buy)
221K
$0.00
1
$173.08M
2021-07-29
2021-08-02
LAMB LAWRENCE
EVP and CSO
A - Grant
Employee Stock Option (right to buy)
61,500
$0.00
1
$173.08M
2021-07-29
2021-08-02
MCCALL PATRICK
Chief Financial Officer
A - Grant
Employee Stock Option (right to buy)
40,000
$0.00
1
$173.08M